Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;60(11):e449-e458.
doi: 10.1111/ijd.15579. Epub 2021 Apr 22.

Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations

Affiliations
Review

Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations

Ana Preda-Naumescu et al. Int J Dermatol. 2021 Nov.

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that is clinically defined by lesions ranging from painful, deep seated nodules to abscesses, draining sinus tracts, and ultimately, irreversible fibrotic scars. While the etiology remains unclear, a number of mechanisms ranging from genetics to aberrations of the immune system have been proposed. In addition, HS has a number of associations and may occur in conjunction with several diseases that span a host of medical specialties. The estimated prevalence ranges are from 1% to 4%; however, a large degree of under-reporting and misdiagnosis of this condition likely underestimates its true clinical significance. The debilitating consequences of missed diagnoses or improper management leads to severe pain and irreversible cutaneous manifestations (i.e., fistulae, sinus tracts, disfiguring scarring). HS has been found to significantly impair patients' quality of life to a greater degree when compared with other skin conditions. Early recognition and treatment are critical for a favorable prognosis, and diagnostic delays may be related to variable presentations within numerous comorbidities. Here we provide an in-depth, clinical-based review of HS, highlighting the clinical presentation, pathophysiology, grading systems, epidemiology, and comorbidities, in hopes of shedding light on an often misunderstood disease and ultimately moving closer to a more conclusive understanding of its various presentations and association.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Kelly G, Sweeney CM, Tobin A-M, et al. Hidradenitis suppurativa: the role of immune dysregulation. Int J Dermatol 2014; 53: 1186-1196.
    1. Nguyen TV, Damiani G, Orenstein L, et al. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol 2021; 35: 50-61.
    1. Alikhan A, Lynch P, Eisen D. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009; 60: 539-561.
    1. Habif T. Clinical Dermatology: A Color Guide to Diagnosis and Therapy, 7. Elsevier, 2016: 215-263.
    1. Jørgensen A, Thomsen S, Karmisholt K, et al. Clinical, microbiological, immunological and imaging characteristics of tunnels and fistulas in hidradenitis suppurativa and Crohn’s disease. Exp Dermatol 2019; 29: 118-123.